PE20150675A1 - Derivados de isoxazolidina - Google Patents

Derivados de isoxazolidina

Info

Publication number
PE20150675A1
PE20150675A1 PE2015000298A PE2015000298A PE20150675A1 PE 20150675 A1 PE20150675 A1 PE 20150675A1 PE 2015000298 A PE2015000298 A PE 2015000298A PE 2015000298 A PE2015000298 A PE 2015000298A PE 20150675 A1 PE20150675 A1 PE 20150675A1
Authority
PE
Peru
Prior art keywords
oxo
isoxazolidine
tetradecahydro
phenanthren
pentalene
Prior art date
Application number
PE2015000298A
Other languages
English (en)
Inventor
Eleonora Ghidini
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47044778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20150675(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PE20150675A1 publication Critical patent/PE20150675A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Otolaryngology (AREA)

Abstract

Referida a un compuesto derivado de isoxazolidina de formula (I). Son compuestos preferidos: 2-[(4aS,4bR,5S,6aS,6bR,9aS,10aS,10bS,12S)-8-(4-cloro-fenil)-4b,12-difluoro-5-hidroxi-4a,6a-dimetil-2-oxo-2,4a,4b,5,6,6a,8,9,9a,10,10a,10b,11,12-tetradecahidro-7-oxa-8-aza-pentalen[2,1-a]fenantren-6b-il]-2-oxo-etilester de acido isobutirico; 2-[(4aS,4bR,5S,6aS,6bR,9aS,10aS,10bS,12S)-8-(4-cloro-fenil)-4b,12-difluoro-5-hidroxi-4a,6a-dimetil-2-oxo-2,4a,4b,5,6,6a,8,9,9a,10,10a,10b,11,12-tetradecahidro-7-oxa-8-aza-pentalen[2,1-a]fenantren-6b-il]-2-oxo-etilester de acido propionico; entre otros. Dichos compuestos son anti-inflamatorios y antialergicos de la serie de los glucocorticosteroides. Tambien esta referida a un metodo de preparacion, composiciones y combinaciones farmaceuticas
PE2015000298A 2012-09-13 2013-08-23 Derivados de isoxazolidina PE20150675A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12184286 2012-09-13

Publications (1)

Publication Number Publication Date
PE20150675A1 true PE20150675A1 (es) 2015-05-20

Family

ID=47044778

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000298A PE20150675A1 (es) 2012-09-13 2013-08-23 Derivados de isoxazolidina

Country Status (28)

Country Link
US (2) US9155747B2 (es)
EP (1) EP2895495B1 (es)
JP (2) JP2015533801A (es)
KR (1) KR101719524B1 (es)
CN (2) CN104619714A (es)
AR (1) AR092547A1 (es)
AU (1) AU2013314539B2 (es)
BR (1) BR112015005500B1 (es)
CA (1) CA2884705C (es)
CL (1) CL2015000610A1 (es)
EA (1) EA027034B1 (es)
ES (1) ES2672140T3 (es)
GE (1) GEP201706708B (es)
HK (1) HK1209756A1 (es)
IL (1) IL237686A (es)
MA (1) MA37927B2 (es)
MX (1) MX364865B (es)
MY (1) MY182523A (es)
NZ (1) NZ705902A (es)
PE (1) PE20150675A1 (es)
PH (1) PH12015500534A1 (es)
PL (1) PL2895495T3 (es)
SA (1) SA515360134B1 (es)
SG (1) SG11201501902RA (es)
TN (1) TN2015000093A1 (es)
UA (1) UA116545C2 (es)
WO (1) WO2014040837A1 (es)
ZA (1) ZA201501691B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI658047B (zh) 2011-03-15 2019-05-01 吉斯藥品公司 異唑啶衍生物
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
KR20200067170A (ko) 2017-10-05 2020-06-11 풀크럼 쎄러퓨틱스, 인코포레이티드 FSHD의 치료를 위하여 DUX4 및 하류 유전자 발현을 저감시키는 p38 키나제 저해제
CN115785188B (zh) * 2022-12-20 2024-06-07 湖南科益新生物医药有限公司 一种布地奈德的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
SE378110B (es) * 1972-05-19 1975-08-18 Bofors Ab
JPS617293A (ja) * 1984-06-20 1986-01-13 Mitsubishi Chem Ind Ltd 新規なコルチコイド誘導体およびその製法
US5888995A (en) * 1991-02-04 1999-03-30 Astra Aktiebolag Steroid esters
WO2003070745A2 (en) * 2002-02-20 2003-08-28 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
JP2011513303A (ja) * 2008-02-27 2011-04-28 アストラゼネカ・アクチエボラーグ 16アルファ,17アルファ−アセタールグルココルチコステロイド誘導体およびその使用
ME01331B (me) 2009-09-11 2013-12-20 Chiesi Farm Spa Derivati izoksazolidina
TW201139369A (en) 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
TWI658047B (zh) 2011-03-15 2019-05-01 吉斯藥品公司 異唑啶衍生物
AR085816A1 (es) * 2011-03-15 2013-10-30 Chiesi Farma Spa Derivados de isoxazolidina
EP2739640A1 (en) * 2011-08-01 2014-06-11 Chiesi Farmaceutici S.p.A. Anti -inflammatory steroids condensed in position 16,17 with pyrrolidine ring

Also Published As

Publication number Publication date
BR112015005500A2 (pt) 2018-05-22
CN108440637A (zh) 2018-08-24
GEP201706708B (en) 2017-07-25
EP2895495A1 (en) 2015-07-22
JP2015533801A (ja) 2015-11-26
US9469669B2 (en) 2016-10-18
MX2015002898A (es) 2015-06-03
CA2884705C (en) 2021-04-13
UA116545C2 (uk) 2018-04-10
CL2015000610A1 (es) 2015-12-04
JP6736607B2 (ja) 2020-08-05
PL2895495T3 (pl) 2018-10-31
CA2884705A1 (en) 2014-03-20
KR101719524B1 (ko) 2017-03-24
BR112015005500B1 (pt) 2022-11-22
ES2672140T3 (es) 2018-06-12
CN104619714A (zh) 2015-05-13
IL237686A (en) 2017-10-31
SG11201501902RA (en) 2015-04-29
WO2014040837A1 (en) 2014-03-20
EA201590390A1 (ru) 2015-08-31
US9155747B2 (en) 2015-10-13
ZA201501691B (en) 2016-10-26
HK1209756A1 (en) 2016-04-08
MA20150350A1 (fr) 2015-10-30
JP2018162270A (ja) 2018-10-18
SA515360134B1 (ar) 2016-07-24
PH12015500534B1 (en) 2015-05-04
MY182523A (en) 2021-01-25
MX364865B (es) 2019-05-09
PH12015500534A1 (en) 2015-05-04
US20150376226A1 (en) 2015-12-31
AR092547A1 (es) 2015-04-22
AU2013314539A1 (en) 2015-04-02
KR20150042264A (ko) 2015-04-20
EA027034B1 (ru) 2017-06-30
US20140069419A1 (en) 2014-03-13
TN2015000093A1 (en) 2016-06-29
EP2895495B1 (en) 2018-05-16
NZ705902A (en) 2018-04-27
AU2013314539B2 (en) 2018-03-08
MA37927B2 (fr) 2021-08-31

Similar Documents

Publication Publication Date Title
CY1122139T1 (el) Χρηση pufas για θεραπεια δερματικης φλεγμονης
CY1120805T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
UY33776A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
PE20150675A1 (es) Derivados de isoxazolidina
CU24272B1 (es) Derivados de tetrahidropirido-pirimidina como inhibidores de mek
GT201300137A (es) Derivados de imidazo [1,2-b] piridazina e imidazo [4,5-b] piridina como inhibidores de jak
CR20130371A (es) IMIDAZO[5,1-f][1,2,4]TRIAZINAS PARA EL TRATAMIENTO DE TRASTORNOS NEUROLÓGICOS
CR20130543A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
MX2015003021A (es) Derivados de acido glicirretinico y metodos de uso de los mismos.
GT201400142A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
PE20140065A1 (es) Sal(es) de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico y procesos para su elaboracion
UY34870A (es) Cristales de sal
CO6511204A2 (es) Derivados de isoxazolidina
TR201903978T4 (tr) L-ornitin fenil asetat yapım yöntemleri.
MX2015011074A (es) Composicion que comprende un compuesto lipido, un triglicerido y un tensioactivo, y metodos de uso de la misma.
NZ629914A (en) New derivatives of 5-aminolevulinic acid and their use as photosensitizing agents
NI201400008A (es) Metabolitos de trans-clomifeno y usos de los mismos
UY35922A (es) Derivados de sulfonamidas tricíclicas
AU2015275248B2 (en) Legumain activated doxorubicin derivative as well as preparation method and application thereof
AU2016204294A1 (en) Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor
GB201319327D0 (en) High purity of caspofungin or salts thereof, and preparation method thereof, and use thereof
UY30582A1 (es) Derivados de acido 2-fenoxinicotinico y su uso
CY1118084T1 (el) ΠΑΡΑΓΩΓΑ ΤΟΥ 7-(ΕΤΕΡΟΑΡΥΛ-ΑΜΙΝΟ)-6,7,8,9-ΤΕΤΡΑΫΔΡΟΠΥΡΙΔΟ[1,2-α]ΙΝΔΟΛΟ ΟΞΙΚΟΥ ΟΞΕΟΣ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΤΡΟΠΟΠΟΙΗΤΕΣ ΤΟΥ ΥΠΟΔΟΧΕΑ ΤΗΣ ΠΡΟΣΤΑΓΛΑΝΔΙΝΗΣ D2
BR112012017485A2 (pt) derivados de ácido carboxílico tendo um anel de oxazolpirimidina 2.5.7-substituído
UA117849C2 (uk) Спосіб одержання 3-заміщених складних ефірів (індол-1-іл)-оцтової кислоти

Legal Events

Date Code Title Description
FG Grant, registration